Moses Rodriguez

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2021
Publications (10 Years): 4

Top Topics

Multiple Sclerosis

Top Venues

Expert review of neurotherapeutics

Journal of neuroinflammation

Molecular neurobiology

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rujapope Sutiwisesak, Terry C Burns, Moses Rodriguez, Arthur E Warrington
Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials. Expert opinion on investigational drugs 30 (8) (2021)
Brandon Wilbanks, Louis James Maher Iii, Moses Rodriguez
Glial cells as therapeutic targets in progressive multiple sclerosis. Expert review of neurotherapeutics 19 (6) (2019)
Maria K Perwein, John A Smestad, Arthur E Warrington, Robin M Heider, Mark W Kaczor, Louis James Maher Iii, Bharath Wootla, Ahmad Kunbaz, Moses Rodriguez
A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next? Expert opinion on biological therapy 18 (5) (2018)
Bharath Wootla, Aleksandar Denic, Jens O Watzlawik, Arthur E Warrington, Laurie J Zoecklein, Louisa M Papke-Norton, Chella David, Moses Rodriguez
Human class I major histocompatibility complex alleles determine central nervous system injury versus repair. Journal of neuroinflammation 13 (1) (2016)
Bharath Wootla, Aleksandar Denic, Jens O Watzlawik, Arthur E Warrington, Moses Rodriguez
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease. Molecular neurobiology 53 (8) (2015)